TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 35 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,324,249 | -42.5% | 7,619,135 | 0.0% | 0.81% | -32.6% |
Q2 2023 | $66,667,431 | -26.1% | 7,619,135 | 0.0% | 1.21% | -31.8% |
Q1 2023 | $90,210,558 | +16.3% | 7,619,135 | 0.0% | 1.77% | +19.3% |
Q4 2022 | $77,562,794 | +76.0% | 7,619,135 | +1.8% | 1.48% | +81.4% |
Q3 2022 | $44,064,000 | +368.7% | 7,481,204 | +97.3% | 0.82% | +381.2% |
Q2 2022 | $9,402,000 | -16.5% | 3,791,204 | 0.0% | 0.17% | -7.1% |
Q1 2022 | $11,260,000 | -58.0% | 3,791,204 | 0.0% | 0.18% | -47.0% |
Q4 2021 | $26,804,000 | -32.1% | 3,791,204 | 0.0% | 0.34% | -20.5% |
Q3 2021 | $39,504,000 | -15.0% | 3,791,204 | 0.0% | 0.43% | -7.7% |
Q2 2021 | $46,480,000 | -44.3% | 3,791,204 | 0.0% | 0.47% | -39.7% |
Q1 2021 | $83,406,000 | – | 3,791,204 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |